• Home
  • Search
  • Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation.
  • Cite Icon2
  • https://doi.org/10.1093/ehjcr/ytae436Copy DOI Icon

Case report: dyslipidaemia-dramatic increase in haemoglobin A1c following statin initiation.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Statin therapy is associated with an increased risk of hyperglycaemia and new-onset diabetes mellitus. The absolute increase in glycosylated haemoglobin (HgbA1c, a measure of average glucose level over the past three months) is typically small; dramatic and clinically relevant increases are rare. A 52-year-old man of South Indian descent with a history of hyperlipidaemia was started on rosuvastatin 40 mg daily for primary prevention of atherosclerotic cardiovascular disease. He did not have a history of diabetes mellitus. He developed polyuria and weight loss within weeks of starting statin therapy. Laboratory assessment was notable for HgA1c of 12.4% and LDL cholesterol of 84 mg/dL. Rosuvastatin was discontinued. He was not started on antidiabetic therapy as there was suspicion that statin therapy was the culprit for his HgbA1c rise. He soon had symptom resolution, and follow-up HgA1c 3 months later was 5.5%. Two years later, patient presented to the hospital with an acute coronary syndrome. He was discharged on rosuvastatin 40 mg daily and developed polyuria 1 week later. Rosuvastatin was discontinued, and atorvastatin 40 mg daily was initiated. Antidiabetic therapy was not started. He had resolution of his symptoms; follow-up HgA1c was below the diabetes threshold. Statins are associated with a small increased risk of developing diabetes mellitus. The beneficial effects of statins on cardiovascular events typically outweigh any increased risk conferred by hyperglycaemia. While high-intensity statin therapy is routinely used as initial therapy for secondary prevention, we have no documentation explaining the choice of high-intensity statin for primary prevention in this case.

Similar Papers
  • Front Matter
  • Citations17

Should all patients receive statins before cardiac surgery: Are more data necessary?

  • Mar 01, 2006
  • The Journal of Thoracic and Cardiovascular Surgery
  • Harold L Lazar
  • Abstract

Lipid-Lowering Therapy for Primary Prevention of Cardiovascular Disease: A Nationwide Analysis of 440,721 Patients

  • Jul 01, 2022
  • Journal of Clinical Lipidology
  • Eric Peterson +6
  • Research Article
  • Citations69

Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat

  • Oct 02, 2019
  • JAMA Cardiology
  • Martin Bødtker Mortensen +1
  • Research Article
  • Citations82

High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.

  • Jul 01, 2017
  • Journal of the American Heart Association
  • T Raymond Foley +9
  • Research Article
  • Citations52

Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.

  • Nov 01, 2014
  • Arteriosclerosis, Thrombosis, and Vascular Biology
  • Rishi Puri +11
  • Research Article
  • Citations10

Perioperative Statin Therapy: Are Formal Guidelines and Physician Education Needed?

  • Jun 01, 2007
  • Anesthesia & Analgesia
  • Manu Sethi +1
  • Research Article
  • Citations9

Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

  • Mar 09, 2019
  • The American Journal of Cardiology
  • Paul Guedeney +17
  • Research Article

P641Patient characteristics and treatment patterns in patients on lipid-lowering therapies following an acute coronary syndrome in France

  • Oct 01, 2019
  • European Heart Journal
  • E Bruckert +5
  • Front Matter
  • Citations210

Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.

  • Oct 28, 2013
  • Circulation
  • Jerome L Fleg +12
  • Research Article
  • Citations35

Effect of Pitavastatin Compared with Atorvastatin andRosuvastatin on New-Onset Diabetes Mellitus in PatientsWith Acute Myocardial Infarction

  • Jun 27, 2018
  • The American Journal of Cardiology
  • Jah Yeon Choi +20
  • Research Article

Abstract 184: Quality Improvement of Statin Therapy Appropriateness in Type 2 Diabetic Patients

  • Mar 01, 2017
  • Circulation: Cardiovascular Quality and Outcomes
  • Dan L Li +4
  • Research Article

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients.

  • Mar 21, 2026
  • Pharmaceuticals (Basel, Switzerland)
  • Rania Abdel-Latif +6
  • Research Article

Impact of team-based health information technology to improve low-density lipoprotein cholesterol goal attainment after acute coronary syndrome hospital discharge: a single-center experience

  • Nov 09, 2023
  • European Heart Journal
  • Y S Chen +2
  • Abstract
  • Citations3

PCV4 - Long-Term Efficacy Of Lower Intensity Statin Therapy In Chinese Acute Coronary Syndrome Patients

  • Sep 01, 2018
  • Value in Health
  • Bp Yan +4
  • Research Article

EARLY USE OF TRIPLE LIPID LOWERING THERAPY IN ACS PATIENTS IN DIFFERENT HOSPITALS

  • May 15, 2025
  • European Heart Journal Supplements
  • B Demichelis +14
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.